Fieldview Capital Management’s Lam Research LRCX Stock Holding History

Fieldview Capital Management’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,695	Closed	-$896K	–	577
2025 Q3	$896K	Buy	+6,695	New	+$709K	0.15%	200
2025 Q2	–	Sell	-3,898	Closed	-$283K	–	445
2025 Q1	$283K	Sell	3,898 -14,795	-79%	-$1.17M	0.04%	349
2024 Q4	$1.35M	Buy	+18,693	New	+$1.42M	0.21%	148

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fieldview Capital Management's LRCX Position: Q4 2025 in Review

Fieldview Capital Management sold out of Lam Research (LRCX) in Q4 2025, closing a stake of 6,695 shares — an estimated $896K sold.

Fieldview Capital Management first reported a position in LRCX in Q4 2024 and held it in 3 quarters. The position peaked at $1.35M in Q4 2024. 2,390 funds tracked by Wall St. Rank hold LRCX as of Q4 2025.

Fieldview Capital Management reported no remaining Lam Research position as of Q4 2025 after selling out during the quarter.
Fieldview Capital Management sold 6,695 Lam Research shares in Q4 2025, an estimated $896K.
Fieldview Capital Management first reported a position in Lam Research in Q4 2024 and held it in 3 quarters.
Fieldview Capital Management's Lam Research position peaked at $1.35M in Q4 2024.
2,390 funds tracked by Wall St. Rank held Lam Research as of Q4 2025.

Based on Fieldview Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.